comprehensive relationships table

© American College of Cardiology Foundation and American Heart Association, Inc.

2013 ACCF/AHA Guideline for the Management of Heart Failure—ONLINE AUTHOR LISTING OF COMPREHENSIVE RELATIONSHIPS WITH

INDUSTRY AND OTHERS (May 2013) Committee

Member

Employment Consultant Speaker’s

Bureau

Ownership/

Partnership/

Principal

Personal Research Institutional,

Organizational or

Other Financial

Benefit

Expert

Witness

Clyde W. Yancy, Chair

Northwestern University—Chief, Division of Cardiology and Magerstadt Professor of Medicine

None None None None • AHA† None

Mariell Jessup, Vice Chair

University of Pennsylvania—Professor of Medicine

None None None • Amgen†

• Celladon†

• HeartWare†

• AHA†

• HFSA†

None

Biykem Bozkurt Michael E. DeBakey VA Medical Center—The Mary and Gordon Cain Chair and Professor of Medicine

None None None • NIH* • Amgen†

• Corthera

• NIH†

• Novartis†

None

Javed Butler

Emory Healthcare—Director of Heart Failure Research; Emory University School of Medicine—Professor of Medicine

None None None None • Amgen

• Biotronic

• Cardiomems

• Corthera

• FoldRx

• iCoapsys

• NIH*

• Johnson &

Johnson—ASCEND-HF

• Medtronic

• Rule 90

• Thoratec

• World Heart Inc.

None

Donald E. Casey, Jr.

Clinically Integrated Physician Network, NYU Langone Medical Center—Vice President and Medical Director

None None None None None None


Mark H. Drazner

University of Texas Southwestern Medical Center—Professor, Internal Medicine

• Optum Health None None • HeartWare†

• NIH/NHLBI*

• American Heart Journal

• Journal of Cardiac Failure

• Medtronic

• Thoratec*

None

Gregg C. Fonarow

Director Ahmanson—UCLA Cardiomyopathy Center; Co-Chief—UCLA Division of Cardiology

• Medtronic

• Novartis*

None None • NHLBI* (Co-I)

• Novartis*

• ACCF/AHA Data Standards Committee

• ACTION Registry GWTG—Steering Chair

• GWTG—Steering Committee

• Medtronic—IMPROVE HF†

None

Stephen A. Geraci

Quillen College of Medicine/East Tennessee State University—Chairman of Internal Medicine


Tamara Horwich

Ahmanson—UCLA Cardiomyopathy Center—Assistant Professor of Medicine, Cardiology

None None • EP Dynamics*

• NHLBI*

• Iris Cantor-UCLA Women’s Health Center

• UCLA Clinical and Transitional Science Institute*

None None

James L. Januzzi Harvard Medical School—Associate Professor of Medicine; Massachusetts General Hospital—Director, Cardiac Intensive Care Unit

• Critical Diagnostics*

• Roche Diagnostics*

None None • Critical Diagnostics*

• Dade-Boehring/ Siemens*

• Roche Diagnostics*

None None

Maryl R. Johnson

University of

Wisconsin−Madison—Professor of Medicine, Director, Heart Failure

• CareMark

• Transmedics (Clinical Trials Committee)

None None None • American Society of Transplantation-Current President

• NIH—Heart Failure

None


and Transplantation Clinical Trials Network (DSMB)

• UNOS Thoracic Organ Committee

Edward K. Kasper

Johns Hopkins Hospital— E. Cowles Andrus Professor in Cardiology Director, Clinical Cardiology


Wayne C. Levy

University of Washington—Professor of Medicine, Division of Cardiology

• Boehringer Ingelheim

• Cardiac Dimensions*

• Thomson Reuters

• GlaxoSmithKline

• Amgen—RED-HF

• HeartWare*

• NIH-DCRI

• Amgen—RED-HF*

• CardioMems—CHAMPION

• Epocrates

• General Electric

• Johnson & Johnson/Scios—ASCEND HF

None None

Frederick A. Masoudi

University of Colorado, Denver—Associate Professor of Medicine, Division of Cardiology

• Axio Research*

None None • ACC*

• AHA

• AHRQ

• Massachusetts Medical Society

• NHLBI*

• Oklahoma Foundation for Medical Quality*

None

Patrick E. McBride

University of Wisconsin School of Medicine and Public Health—Professor of Medicine and Family Medicine, Associate Dean for Students, Associate Director, Preventive Cardiology

None None None None • NIH-NIDDK—LOOK AHEAD (DSMB)

None

John J. V. McMurray

University of Glasgow, Scotland, BHF Glasgow Cardiovascular Research Center—Professor of

None None None • GlaxoSmithKline*

• Novartis

• Oxford/Duke University—

• Novartis—ALTITUDE/ PARADIGM-HF

None


Medical Cardiology EXSCEL (DSMB)

• Oxford/Duke University— TECOS (DSMB)

• Roche—ALECARDIO (DSMB)

Judith E. Mitchell

SUNY Downstate Medical Center—Director, Heart Failure Center; Associate Professor of Medicine

None None None • NHLBI—PRIDE None None

Pamela N. Peterson

University of Colorado, Denver Health Medical Center—Associate Professor of Medicine, Division of Cardiology


Barbara Riegel University of Pennsylvania School of Nursing—Professor

None None None • AHA†

• NIH (PI)*

None None

Flora Sam Boston University School of Medicine, Whitaker Cardiovascular Institute—Associate Professor of Medicine, Division of Cardiology/ Cardiomyopathy Program


Lynne W. Stevenson

Brigham and Women’s Hospital Cardiovascular Division—Director, Cardiomyopathy and Heart Failure Program

None None None • NHLBI†

• NHLBI— INTERMACS†

• Circulation Heart Failure (Senior Associate Editor)†

None

W.H. Wilson Tang

Cleveland Clinic Foundation—Associate Professor of Medicine, Research Director for Heart Failure/Transplant

• Medtronic

• St. Jude Medical*

None • NIH* • Abbott Laboratories

• Asahi Kasei

• FoldRx

• Medtronic

• St. Jude Medical

• HFSA None

Emily J. Tsai Temple University School None None None • AHA Scientist None None


of Medicine—Assistant Professor of Medicine, Cardiology

Development Grant*

• NIH*

• NHLBI

Bruce L. Wilkoff

Cleveland Clinic—Director, Cardiac Pacing and Tachyarrhythmia Devices; Director, Clinical EP Research

None None None • Biotronic

• Boston Scientific

• Medtronic

• St. Jude Medical

None None

This table represents all healthcare relationships of committee members with industry and other entities that were reported by authors, including those not deemed to be relevant to this document, at the time this document was under development. The table does not necessarily reflect relationships with industry at the time of publication. A person is deemed to have a significant interest in a business if the interest represents ownership of ≥5% of the voting stock or share of the business entity, or ownership of ≥$10 000 of the fair market value of the business entity; or if funds received by the person from the business entity exceed 5% of the person’s gross income for the previous year. Relationships that exist with no financial benefit are also included for the purpose of transparency. Relationships in this table are modest unless otherwise noted. Please refer to http://www.cardiosource.org/Science-And-Quality/Practice-Guidelines-and-Quality-Standards/Relationships-With-Industry-Policy.aspx for definitions of disclosure categories or additional information about the ACCF/AHA Disclosure Policy for Writing Committees.

*Indicates significant relationship.

†No financial benefit. ACC indicates American College of Cardiology; AHA, American Heart Association; AHEAD, Action For Health in Diabetes; AHRQ, Agency for Healthcare Research & Quality; ALECARDIO, Cardiovascular Outcomes Study to Evaluate the Potential of Aleglitazar to Reduce Cardiovascular Risk in Patients With a Recent Acute Coronary Syndrome Event and Type 2 Diabetes Mellitus; ALTITUDE, Aliskiren Trial in Type 2 Diabetes Using Cardio-Renal Endpoints; ASCEND-HF, Acute Study of Clinical Effectiveness of Nesiritide in Decompensated Heart Failure; CHAMPION, CardioMEMS Heart Sensor Allows Monitoring of Pressure to Improve Outcomes in NYHA Class III Patients; DCRI, Department of Clinical Research Informatics; DSMB, Data Safety Monitoring Board; EP, electrophysiology; EXSCEL, Exenatide Study of Cardiovascular Event Lowering; GWTG, Get With The Guidelines; HF, heart failure; HFSA, Heart Failure Society of America; IMPROVE HF, Registry to Improve the Use of Evidence-Based Heart Failure Therapies in the Outpatient Setting; INTERMACS, Interagency Registry for Mechanically Assisted Circulatory Support; NHLBI, National Heart, Lung, and Blood Institute; NIDDK, National Institute of Diabetes and Digestive and Kidney Diseases; NIH, National Institute of Health; NYU, New York University; PARADIGM-HF, Prospective Comparison of ARNI With ACEI to Determine Impact on Global Mortality and Morbidity in Patients With Heart Failure; PRIDE, Prolonging Remission in Depressed Elderly; SUNY, State University of New York; TECOS, Trial Evaluating Cardiovascular Outcomes with Sitagliptin in Patients with Type 2 Diabetes; UCLA, University of California, Los Angeles; UNOS, United Network for Organ Sharing; and VA, veterans affairs.

comprehensive relationships table

Documents